ArticleNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2026
Linguistic validation and reliability of the Brazilian Portuguese version of the Composite Autonomic Symptom Score 31 (COMPASS 31).
Article in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe Composite Autonomic Symptom Score 31 (COMPASS-31) is a validated self-report questionnaire designed to assess autonomic symptoms across six domains. A Brazilian Portuguese version has not yet been formally validated.
methodsFollowing a standardized Mayo Clinic linguistic validation protocol, the COMPASS-31 was translated into Brazilian Portuguese. Twenty-one patients with disorders associated with autonomic symptoms and nine healthy controls completed both the English and Portuguese versions in randomized order, with a six-week interval between administrations. Reliability was assessed using kappa coefficients and Bland–Altman analysis. Validity was evaluated by comparing scores between patients and controls and by correlating the Portuguese and English versions.
resultsThe Brazilian Portuguese version of the COMPASS-31 demonstrated good test–retest reliability and a strong correlation with the original English version (r = 0.784, p < 0.0001). Patients exhibited significantly higher total scores than healthy controls. Bland–Altman analysis showed good agreement, with 93.4% of values falling within the limits of agreement.
conclusionsThe Brazilian Portuguese version of the COMPASS-31 is a valid and reliable instrument for assessing autonomic symptoms in both clinical and research settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.